Spectral Medical Appoints Former FDA Director, Dr. David W. Feigal, Jr., to Its Board of Directors

TORONTO, June 27, 2023 (GLOBE NEWSWIRE) —

Related Keywords

California ,United States ,Canada ,Toronto ,Ontario ,Berkeley ,San Francisco ,Stanford University ,New York ,Japan ,San Diego ,America ,Ali Mahdavi ,Jake Edmiston ,Blair Mcinnis ,David Waldman Natalya Rudman ,Chris Seto ,Kevin Carmichael ,Davidw Feigal Jr ,Gabriel Friedman ,Anthony Bihl ,Division Of Anti ,Amgen Inc ,World Health Organization ,Toronto Stock Exchange ,Human Services ,Office Of Drug ,Spectral Medical Inc ,Master Of Public Health ,Us Department Of Health ,Propharma Company ,National Post ,University Of California ,Spinnaker Capital Markets Inc ,Radiological Health ,Drug Administration ,Postmedia Network Inc ,Elan Pharmaceuticals Inc ,Global Regulatory Affairs ,Crescendo Communications ,University Of Minnesota ,Company Endotoxin Activity Assay ,National Institutes Of Health ,Global Requlatory Affairs ,Deputy Center ,European Medicines Evaluation Agency ,Spectral Medical Appoints Former ,Its Board ,Spectral Medical ,Vice President ,Elan Pharmaceuticals ,Senior Vice President ,Global Safety Surveillance ,Victoria Wells ,Financial Times ,Financial Post ,New York Times ,Postmedia Network ,Street East ,Drug Evaluation ,Anti Viral Drug Products ,Acting Director ,Anti Infective Drug Products ,Medical Deputy Center Director ,Center Director ,National Institutes ,Public Health ,Chief Executive Officer ,Endotoxin Activity Assay ,Breakthrough Device Designation ,North America ,